Novartis Exec Scherer Joins Cellectis as Deputy Chief Medical Officer

Stefan Scherer has been appointed senior vice president of clinical development and deputy chief medical officer of Cellectis (NASDAQ: [[ticker:CLLS]]). He comes to the French cell therapy developer from Novartis (NYSE: [[ticker:NVS]]), where he was head of early development, strategy, and innovation for U.S. oncology. Scherer will be based in New York. Cellectis is developing new cancer immunotherapies based on gene-edited T-cells.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.